Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)

BACKGROUND: Telavancin is a lipoglycopeptide with multiple mechanisms of action that include membrane-destabilizing effects towards bacterial cells. It shows bactericidal activity against forms of Staphylococcus aureus (phagolysosomal infection) with different resistance phenotypes [methicillin-resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcia-Macay, Maritza, Mouaden, Fatima, Mingeot-Leclercq, Marie-Paule, Tulkens, Paul M., Van Bambeke, Françoise
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386079/
https://www.ncbi.nlm.nih.gov/pubmed/18375379
http://dx.doi.org/10.1093/jac/dkn120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386079/
https://www.ncbi.nlm.nih.gov/pubmed/18375379
http://dx.doi.org/10.1093/jac/dkn120

Ejemplares similares